318 related articles for article (PubMed ID: 30787418)
1. Transcriptional regulation of Hepatic Stellate Cell activation in NASH.
Marcher AB; Bendixen SM; Terkelsen MK; Hohmann SS; Hansen MH; Larsen BD; Mandrup S; Dimke H; Detlefsen S; Ravnskjaer K
Sci Rep; 2019 Feb; 9(1):2324. PubMed ID: 30787418
[TBL] [Abstract][Full Text] [Related]
2. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.
Bates J; Vijayakumar A; Ghoshal S; Marchand B; Yi S; Kornyeyev D; Zagorska A; Hollenback D; Walker K; Liu K; Pendem S; Newstrom D; Brockett R; Mikaelian I; Kusam S; Ramirez R; Lopez D; Li L; Fuchs BC; Breckenridge DG
J Hepatol; 2020 Oct; 73(4):896-905. PubMed ID: 32376414
[TBL] [Abstract][Full Text] [Related]
3. SIRT6 Protects Against Liver Fibrosis by Deacetylation and Suppression of SMAD3 in Hepatic Stellate Cells.
Zhong X; Huang M; Kim HG; Zhang Y; Chowdhury K; Cai W; Saxena R; Schwabe RF; Liangpunsakul S; Dong XC
Cell Mol Gastroenterol Hepatol; 2020; 10(2):341-364. PubMed ID: 32305562
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the Role of Stellate Cell VCAM-1 in NASH Models in Mice.
Chung KJ; Legaki AI; Papadopoulos G; Gercken B; Gebler J; Schwabe RF; Chavakis T; Chatzigeorgiou A
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902241
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional repression of SIRT1 by protein inhibitor of activated STAT 4 (PIAS4) in hepatic stellate cells contributes to liver fibrosis.
Sun L; Fan Z; Chen J; Tian W; Li M; Xu H; Wu X; Shao J; Bian Y; Fang M; Xu Y
Sci Rep; 2016 Jun; 6():28432. PubMed ID: 27323886
[TBL] [Abstract][Full Text] [Related]
6. LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease.
Ceccarelli S; Panera N; Mina M; Gnani D; De Stefanis C; Crudele A; Rychlicki C; Petrini S; Bruscalupi G; Agostinelli L; Stronati L; Cucchiara S; Musso G; Furlanello C; Svegliati-Baroni G; Nobili V; Alisi A
Oncotarget; 2015 Dec; 6(39):41434-52. PubMed ID: 26573228
[TBL] [Abstract][Full Text] [Related]
7. Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells.
Chong LW; Hsu YC; Lee TF; Lin Y; Chiu YT; Yang KC; Wu JC; Huang YT
BMC Gastroenterol; 2015 Feb; 15():22. PubMed ID: 25886887
[TBL] [Abstract][Full Text] [Related]
8. Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice.
Kim KH; Kim SH; Han DH; Jo YS; Lee YH; Lee MS
Sci Rep; 2018 May; 8(1):6789. PubMed ID: 29717162
[TBL] [Abstract][Full Text] [Related]
9. Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis.
Cai CX; Buddha H; Castelino-Prabhu S; Zhang Z; Britton RS; Bacon BR; Neuschwander-Tetri BA
Dig Dis Sci; 2017 Apr; 62(4):968-978. PubMed ID: 28194671
[TBL] [Abstract][Full Text] [Related]
10. CD8
Breuer DA; Pacheco MC; Washington MK; Montgomery SA; Hasty AH; Kennedy AJ
Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G211-G224. PubMed ID: 31709830
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease.
Dongiovanni P; Meroni M; Baselli GA; Bassani GA; Rametta R; Pietrelli A; Maggioni M; Facciotti F; Trunzo V; Badiali S; Fargion S; Gatti S; Valenti L
Clin Sci (Lond); 2017 Jun; 131(12):1301-1315. PubMed ID: 28468951
[TBL] [Abstract][Full Text] [Related]
12. Expression of hepatic stellate cell activation-related genes in HBV-, HCV-, and nonalcoholic fatty liver disease-associated fibrosis.
He L; Yuan H; Liang J; Hong J; Qu C
PLoS One; 2020; 15(5):e0233702. PubMed ID: 32442221
[TBL] [Abstract][Full Text] [Related]
13. Metformin ameliorates activation of hepatic stellate cells and hepatic fibrosis by succinate and GPR91 inhibition.
Nguyen G; Park SY; Le CT; Park WS; Choi DH; Cho EH
Biochem Biophys Res Commun; 2018 Jan; 495(4):2649-2656. PubMed ID: 29278707
[TBL] [Abstract][Full Text] [Related]
14. TGF-β1-driven reduction of cytoglobin leads to oxidative DNA damage in stellate cells during non-alcoholic steatohepatitis.
Okina Y; Sato-Matsubara M; Matsubara T; Daikoku A; Longato L; Rombouts K; Thanh Thuy LT; Ichikawa H; Minamiyama Y; Kadota M; Fujii H; Enomoto M; Ikeda K; Yoshizato K; Pinzani M; Kawada N
J Hepatol; 2020 Oct; 73(4):882-895. PubMed ID: 32330605
[TBL] [Abstract][Full Text] [Related]
15. Adipose tissue-derived stem cells prevent fibrosis in murine steatohepatitis by suppressing IL-17-mediated inflammation.
Yamato M; Sakai Y; Mochida H; Kawaguchi K; Takamura M; Usui S; Seki A; Mizukoshi E; Yamashita T; Yamashita T; Ishida K; Nasti A; Tuyen HTB; Komura T; Yoshida K; Wada T; Honda M; Kaneko S
J Gastroenterol Hepatol; 2019 Aug; 34(8):1432-1440. PubMed ID: 30828861
[TBL] [Abstract][Full Text] [Related]
16. Imaging Fibrogenesis in a Diet-Induced Model of Nonalcoholic Steatohepatitis (NASH).
Hartimath SV; Boominathan R; Soh V; Cheng P; Deng X; Chong YC; Yong FF; Tan PW; Han W; Robins EG; Goggi JL
Contrast Media Mol Imaging; 2019; 2019():6298128. PubMed ID: 31866798
[TBL] [Abstract][Full Text] [Related]
17. Novel oral SPT inhibitor CH5169356 inhibits hepatic stellate cell activation and ameliorates hepatic fibrosis in mouse models of non-alcoholic steatohepatitis (NASH).
Hada N; Katsume A; Kenichi K; Endo C; Horiba N; Sudoh M
Pharmacol Res Perspect; 2023 Jun; 11(3):e01094. PubMed ID: 37204099
[TBL] [Abstract][Full Text] [Related]
18. Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic Treatment of Non-Alcoholic Fatty Liver Disease.
Kimura T; Singh S; Tanaka N; Umemura T
Front Endocrinol (Lausanne); 2021; 12():773432. PubMed ID: 34938271
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of EGFR attenuates fibrosis and stellate cell activation in diet-induced model of nonalcoholic fatty liver disease.
Liang D; Chen H; Zhao L; Zhang W; Hu J; Liu Z; Zhong P; Wang W; Wang J; Liang G
Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):133-142. PubMed ID: 29038049
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of HSCs in a Mouse Model of NASH.
Rosenthal SB; Liu X; Ganguly S; Dhar D; Pasillas MP; Ricciardelli E; Li RZ; Troutman TD; Kisseleva T; Glass CK; Brenner DA
Hepatology; 2021 Aug; 74(2):667-685. PubMed ID: 33550587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
